A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Health Organization Group 1 Pulmonary Hypertension Who Recently Initiated Therapy (ADVANCE Capacity)
Obert
- Codi protocol: ROR-PH-302
- Codi EudraCT: 2019-003309-88
- Grup de recerca: Pneumologia
- Servei: Pneumologia
- Investigador/a principal: López Meseguer, Manuel
- Malaltia: Malalties del sistema respiratori
- Fase: Fase III